Mycobacterium abscessus infections in lung transplant recipients: 15-year experience from a single institution

Transplant Infectious Disease

Volumn 20, Issue 2, 2018, Pages

  Osmani, Morsal ^a   Sotello, David ^a   Alvarez, Salvador ^a   Odell, John A ^a   Thomas, Mathew ^a  

^a MAYO CLINIC   (United States)

Author keywords

lung transplantation; mycobacterial infections; Mycobacterium abscessus; non tuberculous mycobacterium; rapidly growing mycobacterium

Indexed keywords

AMIKACIN; AZATHIOPRINE; AZITHROMYCIN; CEFOXITIN; CLARITHROMYCIN; CREATININE; LINEZOLID; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BODY WEIGHT LOSS; BRAIN HEMORRHAGE; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; BRONCHUS OBSTRUCTION; CARDIOPULMONARY BYPASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; COUGHING; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; CYTOPENIA; DIARRHEA; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPNEA; ELECTRONIC HEALTH RECORD; FEMALE; FEVER; FIBROSING ALVEOLITIS; FOLLOW UP; GRAFT RECIPIENT; HEMATOTHORAX; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MEDIAN SURVIVAL TIME; MEDICAL RECORD REVIEW; MIDDLE AGED; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS INFECTION; MYCOBACTERIUM CHELONAE INFECTION; NEUROPATHY; NIGHT SWEAT; OSTEOMYELITIS; OTOTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY; ATYPICAL MYCOBACTERIOSIS; HOSPITAL; MYCOBACTERIUM ABSCESSUS; RISK FACTOR;

ADULT; AGED; HOSPITALS; HUMANS; LUNG TRANSPLANTATION; MIDDLE AGED; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANT RECIPIENTS;

EID: 85041861358     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12835     Document Type: Article

References (28)

1. Donohue MJ, Mistry JH, Donohue JM, et al. Increased frequency of nontuberculous mycobacteria detection at potable water taps within the United States. Environ Sci Technol. 2015;49:6127-6133.
2. Baker AW, Lewis SS, Alexander BD, et al. Two-phase hospital-associated outbreak of Mycobacterium abscessus: Investigation and mitigation. Clin Infect Dis. 2017;64:902-911.
3. Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis. 2015;21:1638-1646.
4. Kim J, Sung H, Park JS, Choi SH, Shim TS, Kim MN. Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea. Int J Tuberc Lung Dis. 2016;20:109-114.
5. Koh WJ, Jeong BH, Kim SY, et al. Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease. Clin Infect Dis. 2017;64:309-316.
6. Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. Mycobacterium abscessus: A new antibiotic nightmare. J Antimicrob Chemother. 2012;67:810-818.
7. Taylor JL, Palmer SM. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant. 2006;25:985-988.
8. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416.
9. Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: A retrospective cohort study. Lancet. 2013;381:1551-1560.
10. Sanguinetti M, Ardito F, Fiscarelli E, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol. 2001;39:816-819.
11. Knoll BM, Kappagoda S, Gill RR, et al. Non-tuberculous mycobacterial infection among lung transplant recipients: A 15-year cohort study. Transpl Infect Dis. 2012;14:452-460.
12. Shah SK, McAnally KJ, Seoane L, et al. Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation. Transpl Infect Dis. 2016;18:585-591.
13. Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1611-1616.
14. Huang HC, Weigt SS, Derhovanessian A, et al. Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality. J Heart Lung Transplant. 2011;30:790-798.
15. Longworth SA, Vinnard C, Lee I, Sims KD, Barton TD, Blumberg EA. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: A case-control study. Transpl Infect Dis. 2014;16:76-83.
16. Chernenko SM, Humar A, Hutcheon M, et al. Mycobacterium abscessus infections in lung transplant recipients: The international experience. J Heart Lung Transplant. 2006;25:1447-1455.
17. Gilljam M, Schersten H, Silverborn M, Jonsson B, Ericsson HA. Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection. J Cyst Fibros. 2010;9:272-276.
18. Lobo LJ, Chang LC, Esther CR Jr, Gilligan PH, Tulu Z, Noone PG. Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections. Clin Transplant. 2013;27:523-529.
19. Roux AL, Catherinot E, Soismier N, et al. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. J Cyst Fibros. 2015;14:63-69.
20. Medical Section of the American Lung Association. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Am J Respir Crit Care Med. 1997;156(2 Pt 2):S1-S25.
21. Olivier KN, Weber DJ, Wallace RJ Jr, et al. Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167:828-834.
22. Morales P, Ros JA, Blanes M, Perez-Enguix D, Saiz V, Santos M. Successful recovery after disseminated infection due to Mycobacterium abscessus in a lung transplant patient: Subcutaneous nodule as first manifestation – A case report. Transplant Proc. 2007;39:2413-2415.
23. Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplant Proc. 2010;42:3058-3060.
24. Qvist T, Eickhardt S, Kragh KN, et al. Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection. Eur Respir J. 2015;46:1823-1826.
25. Kim HS, Lee KS, Koh WJ, et al. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. Radiology. 2012;263:260-270.
26. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis. 1993;147:1271-1278.
27. Jeon K, Kwon OJ, Lee NY, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: A retrospective analysis of 65 patients. Am J Respir Crit Care Med. 2009;180:896-902.
28. Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 2014;6:210-220.